An Artificial Intelligence- based tool called ‘ PIVOT ’ has been developed by researchers at the Indian institute of Technology Madras( IIT Madras).
- PIVOT is able of predicting cancer- causing genes in patients.
- This AI- based tool will help in formulating strategies for individualized cancer treatment.
- PIVOT has been designed to predict genes which are responsible for causing cancer.
On which model was PIVOT developed?
The PIVOT tool was developed on the base of a machine learning model, which divides genes as tumour oncogenes, suppressor genes, or neutral genes. It successfully prognosticated the oncogenes as well as tumour- suppressor genes similar as TP53, and PIK3CA. This tool is also able to foresee new cancer- related genes similar as PRKCA, SOX9 and PSMD4.
PIVOT is a machine learning tool. It uses different data, including mutation & gene expression, to prevision the cancer- causing genes. These genes are called driver genes. It helps in formulating personalised cancer treatment strategies. originally, it uses supervised model learns( ML) algorithms from known driver genes in patient. Patient data and corresponding personalised driver genes are unknown. Secondly, this tool makes use of models on multiple data types, considering the expression data, mutation data, and combination of all types of data.
Final solution: The Hindu Editorial on giving earth a change to escape climate change effects
The influential Intergovernmental Panel on Climate Change (IPCC) has made public its final ‘Synthesis’ report, which is part of the Sixth Assessment Cycle. Since 1990, when the IPCC began publicising its compilation of global scientific research linking...
Mallya bought properties in England, France while airline in crisis: CBI
Beleaguered businessman Vijay Mallya bought properties worth Rs 330 crore in England and France during 2015-16 even as his Kingfisher Airlines was facing a cash crunch at that time and banks had not recovered the loans...
Uzbek kids’ death: Licence of Marion Biotech cancelled by UP authority
The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech was cancelled on Wednesday by Uttar Pradesh authorities, according to officials. Marion Biotech's cough syrup Dok-1 was linked with the...